Home
Home
Phadia Development Business
April 25, 2008 |
Phadia Development Business (PDB)
- Customized products for industrial applications

Phadia has over 30 years experience of in vitro testing of allergy and autoimmune diseases. ImmunoCAP is the only system optimized for the high requirements of IgE antibody testing. Other tests based on the same technology include Specific IgA, Specific IgG, Specific IgG4, Specific IgM and specific markers for asthma and inflammation (ECP and Tryptase).

Based on our solid experience, Phadia Development Business develops customized applications using our technologies and products to meet the specific needs of our industrial customers.

How can we meet your needs?
 

If your company 
  • Develops new drugs and you need to monitor immunological responses
  • Produces or develops enzymes and you need to monitor your staff
  • Produces substances which may cause allergy related occupational problems
  • Performs clinical studies in the field of allergy or autoimmunity
  • Needs large amounts of purified allergen components
  • Wants to measure IgE, IgG, IgG4, IgM or IgA antibodies to allergens/antigens by immunological techniques

Then Phadia can help

  • Reduce the time required
  • Reduce the risk involved
  • Minimize test monitoring

Interested?

For more detailed information regarding PDB, please get in touch with Phadia in Uppsala, Sweden on e-mail address pdb@phadia.com

Commercial terms
Phadia Development Business operates in accordance with normal industrial practices, including clear quotations, secrecy agreements and, if desired, contracts developed together with the client.